Chemoinformaics analysis of 26,27-Dinorcholesta-5,22-Dien-3-Ol, (3.Beta.,22e)-
| Molecular Weight | 356.594 | nRot | 3 |
| Heavy Atom Molecular Weight | 316.274 | nRig | 21 |
| Exact Molecular Weight | 356.308 | nRing | 4 |
| Solubility: LogS | -6.71 | nHRing | 0 |
| Solubility: LogP | 6.437 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 69.2237 |
| nHD | 1 | BPOL | 40.1283 |
| QED | 0.57 |
| Synth | 4.377 |
| Natural Product Likeliness | 3.047 |
| NR-PPAR-gamma | 0.038 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.024 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.622 |
| MDCK | 0.0000104 |
| BBB | 0.666 |
| PPB | 0.985233 |
| VDSS | 1.967 |
| FU | 0.0184321 |
| CYP1A2-inh | 0.105 |
| CYP1A2-sub | 0.582 |
| CYP2c19-inh | 0.086 |
| CYP2c19-sub | 0.931 |
| CYP2c9-inh | 0.17 |
| CYP2c9-sub | 0.361 |
| CYP2d6-inh | 0.045 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.339 |
| CYP3a4-sub | 0.458 |
| CL | 17.543 |
| T12 | 0.03 |
| hERG | 0.007 |
| Ames | 0.031 |
| ROA | 0.038 |
| SkinSen | 0.052 |
| Carcinogencity | 0.159 |
| EI | 0.012 |
| Respiratory | 0.352 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.741964 |